What are the commercial prospects for pharmaceutical freeze-drying? Visiongain's brand new report gives you revenue predictions for the lyophilisation for pharmaceuticals market and its submarkets to ...
SMi reports: There are two post-conference workshops taking place on the 5 th June 2019, which will explain lyophilisation in its most simplistic terms. Attendees of this workshop will gain basic ...
SMi Group Reports: The 7th Annual Conference for Lyophilisation taking place on the 3rd- 4th of June plus a two day interactive workshop on the 5th of June 2019 in London, UK. Pharmaceutical freeze ...
http://www.reportlinker.com/p0578544/Lyophilisation-for-Pharmaceuticals-Technology-and-Services-Market-2011-2021---what-are-the-revenue-prospects.html#utm_source ...
Lyophilization is an expensive process that demands high investments in technology, but for many products, pharmaceutical freeze drying is currently the only method to ensure durability.
Genevac announces that state-of-the-art condenser technology enables its HT Series 3 evaporator, using FastLyo methodology, to set a new benchmark for fast and efficient sample lyophilisation. A ...
Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a new bulk lyophilisation (freeze drying) service after winning several new contracts in this niche area.
SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for ...
What are the commercial prospects for pharmaceutical freeze-drying? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our ...
Genevac has announced the new SuperCool 75 - a condenser that in conjunction with its HT-12 High Throughput Evaporator has been proven to set a new benchmark for enhanced evaporation and ...
A new report by visiongain predicts that the 2012 world market for lyophilisation (freeze drying) products and services for pharma will reach $2.48 billion. That revenue forecast and others appear in ...